Renaissance Technologies
IMVT icon

Renaissance Technologies’s Immunovant IMVT Stock Holding History

Renaissance Technologies’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Buy
726,800
+534,300
+278% +$16.3M 0.04% 562
2026
Q1 		$4.78M Buy
+192,500
New +$4.98M 0.01% 1411
2025
Q3 		– Sell
-241,400
Closed -$3.86M – 3690
2025
Q2 		$3.86M Sell
241,400
-154,500
-39% -$2.34M 0.01% 1678
2025
Q1 		$6.77M Buy
395,900
+315,000
+389% +$6.59M 0.01% 1234
2024
Q4 		$2M Sell
80,900
-108,100
-57% -$3.07M ﹤0.01% 2053
2024
Q3 		$5.39M Sell
189,000
-199,100
-51% -$5.87M 0.01% 1398
2024
Q2 		$10.2M Buy
388,100
+48,400
+14% +$1.38M 0.02% 906
2024
Q1 		$11M Buy
339,700
+321,400
+1,756% +$11.7M 0.02% 939
2023
Q4 		$771K Sell
18,300
-203,100
-92% -$7.47M ﹤0.01% 2561
2023
Q3 		$8.5M Sell
221,400
-246,400
-53% -$5.57M 0.01% 1015
2023
Q2 		$8.87M Sell
467,800
-24,312
-5% -$453K 0.01% 1093
2023
Q1 		$7.63M Buy
492,112
+148,012
+43% +$2.57M 0.01% 1234
2022
Q4 		$6.11M Sell
344,100
-8,400
-2% -$106K 0.01% 1393
2022
Q3 		$1.97M Buy
352,500
+19,900
+6% +$97.3K ﹤0.01% 2020
2022
Q2 		$1.3M Buy
332,600
+231,900
+230% +$1M ﹤0.01% 2530
2022
Q1 		$555K Buy
100,700
+83,100
+472% +$518K ﹤0.01% 3119
2021
Q4 		$150K Buy
+17,600
New +$145K ﹤0.01% 3606
2021
Q1 		– Sell
-5,600
Closed -$259K – 3492
2020
Q4 		$259K Buy
+5,600
New +$259K ﹤0.01% 3078
2020
Q3 		– Sell
-36,300
Closed -$884K – 3508
2020
Q2 		$884K Buy
+36,300
New +$778K ﹤0.01% 2601

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies's IMVT Position: Q2 2026 in Review

Renaissance Technologies increased its Immunovant (IMVT) stake by 278% in Q2 2026, buying an estimated $16.3M and bringing the position to 726,800 shares worth $28M. The position accounts for 0.04% of the portfolio, ranked #562.

Renaissance Technologies first reported a position in IMVT in Q2 2020 and has held it in 19 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Renaissance Technologies held 726,800 shares of Immunovant worth $28M as of Q2 2026.
  • Renaissance Technologies bought 534,300 Immunovant shares in Q2 2026, an estimated $16.3M.
  • Immunovant made up 0.04% of Renaissance Technologies's portfolio in Q2 2026, its #562 holding.
  • Renaissance Technologies first reported a position in Immunovant in Q2 2020 and has held it in 19 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.